JDRF Continuous Glucose Monitoring Trial Results to be Announced in Rome on September 8

Exciting news for continuous glucose monitoring (CGM) watchers: Much of the diabetes world is descending in Rome over the next couple of days for the big European Association for the Study of Diabetes (EASD) meeting happening starting tomorrow! We'll be there covering the meeting for our publications. On an exciting note, we have just confirmed the JDRF continuous glucose monitoring (CGM) trial results will be presented Monday at noon Rome time.  See below for the all-start lineup for this session. The session will include background on the trial, information on how it was designed, data on what happened in the trial, implications for patients, and what is sure to be a closely-watched panel led by influential pediatric endocrinologist Dr. Bill Tamborlane of Yale. We see this session as very relevant for further progress on reimbursement and CGM uptake. (Sidenote - if you want to wear CGM and have Humana insurance, they just published a positive new coverage issue on CGM - click here for details.)

******

JDRF TRIAL ANNOUNCEMENT SCHEDULE
There will be a presentation of the first results from the Juvenile Diabetes Research Foundation (JDRF)-funded human clinical trial investigating the efficacy of continuous glucose sensors on diabetes control.
 
JDRF Study Group: Presentation of JDRF Study Group Primary Cohort Six Month Outcome Data
44th EASD Annual Meeting Rome, Italy
Monday 8 September, 12.00 - 14.00 hrs
Domizia room in Hall 10 of the Fiera di Roma.
 
MEETING AGENDA
 
BACKGROUND/RATIONALE
·         Aaron J. Kowalski, Ph.D., JDRF (moderator)
 
STUDY DESIGN
·         Jean Lawrence Sc.D., Kaiser Permanente Southern California
 
PRIMARY OUTCOMES
·         William Tamborlane, M.D., Yale Medical School
 
SENSOR OUTCOME DATA
·         Howard Wolpert, M.D., Joslin Diabetes Clinic
 
IMPLICATIONS OF RESULTS FOR ADULTS WITH TYPE 1 DIABETES
·         Irl Hirsch, M.D., University of Washington
 
IMPLICATIONS OF RESULTS FOR CHILDREN WITH TYPE 1 DIABETES
·         Lori Laffel, M.D., M.P.H, Joslin Diabetes Clinic
 
PANEL DISCUSSION
·         Moderated by W. Tamborlane (all speakers)